arrow
返回
R

Richard A. Rifkind

机构信息待补充

58H指数
155论文数
1.7W被引数
收录论文 12
发表时间
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation
err2007-01-19
err98
errOAAI
errMarrocco, Deborah L.; Tilley, Wayne D.; Bianco-Miotto, Tina; Evdokiou, Andreas; Scher, Howard I.; Rifkind, Richard A.; Marks, Paul A.; Richon, Victoria M.; Butler, Lisa M.
err分享
err收藏
Histone deacetylases and cancer: Causes and therapies组蛋白去乙酰化酶与癌症: 原因和治疗
err2001-12-01
err1.9K
PREAI
errMarks, PA; Rifkind, RA; Richon, VM; Breslow, R; Miller, T; Kelly, WK
err分享
err收藏
Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia
err2001-11-01
err293
errOAAI
errHe, LZ; Tolentino, T; Grayson, P; Zhong, S; Warrell, RP; Rifkind, RA; Marks, PA; Richon, VM; Pandolfi, PP
err分享
err收藏
Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents
err1999-05-01
err45
errOAAI
errWebb, Y; Zhou, XB; Ngo, L; Cornish, V; Stahl, J; Erdjument-Bromage, H; Tempst, P; Rifkind, RA; Marks, PA; Breslow, R; Richon, VM
err分享
err收藏
ERYTHROLEUKEMIC DIFFERENTIATION
err1978-06-01
err874
PREAI
errMARKS, PA; RIFKIND, RA
err分享
err收藏